Mucuna pruriens seeds contain about 5% L-dihydroxyphenylalanine, L-Dopa, a compound which is widely used in the management of nervous disorders such as Parkinson’s disease. Other compounds in the seeds include bufotenine and serotonin which reduce cholinesterase activity thereby helping to attenuate brain functions.

The endocarp of the beans contain the maximum L-Dopa concentration. Four varieties of seed have been observed.

Formulation development assistance from Sabinsa Corporation Ingredient compatibility, safety and stability are key concern